HSBC HOLDINGS PLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$394,000
+3.4%
8,485
-5.4%
0.00%0.0%
Q3 2020$381,000
+4.1%
8,972
+17.7%
0.00%0.0%
Q2 2020$366,000
+81.2%
7,621
+73.8%
0.00%
Q1 2020$202,000
-32.0%
4,386
-11.2%
0.00%
-100.0%
Q4 2019$297,000
-49.7%
4,938
-52.6%
0.00%0.0%
Q3 2019$590,00010,4210.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders